Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
E
EPI
vs
S
S&P/ASX 300
Over the past 12 months, EPI has underperformed S&P/ASX 300, delivering a return of -78% compared to S&P/ASX 300's 3% drop.
Stocks Performance
EPI vs S&P/ASX 300
Performance Gap
EPI vs S&P/ASX 300
Performance By Year
EPI vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Epiminder Ltd
Glance View
Epiminder Ltd is a medical technology company that develops tools for monitoring epilepsy outside the hospital. Its main product is designed to record brain activity over long periods so doctors can better detect and understand seizures and other abnormal electrical activity. The company sells this technology to neurologists, hospitals, and epilepsy clinics that need more continuous information than a short in-office test can provide. The business makes money by selling or licensing its monitoring system and the related data analysis software and services that go with it. In simple terms, Epiminder sits between the patient and the doctor: it collects brain-signal data, turns it into useful medical information, and helps clinicians make treatment decisions. That makes it different from many device makers because the value is not just the hardware, but also the long-duration monitoring and interpretation of the data. Epiminder’s role in the healthcare chain is to give specialists a clearer view of epilepsy outside a brief clinic visit or standard EEG exam. Its customers are mainly medical professionals and healthcare providers treating people with epilepsy, and its revenue comes from the sale and use of its monitoring technology rather than from drugs or general hospital equipment.